Sodium–Glucose Cotransporter 2 Inhibitors, Glucagon-Like Peptide 1 Receptor Agonists, and Frailty Progression in Older Adults With Type 2 Diabetes. Diabetes Care 2026;49:147–151

Simple item page
dc.contributor.authorPark C.M.
dc.contributor.authorThanapluetiwong S.
dc.contributor.authorChen X.
dc.contributor.authorOh G.
dc.contributor.authorKo D.
dc.contributor.authorKim D.H.
dc.contributor.correspondencePark C.M.
dc.contributor.otherMahidol University
dc.date.accessioned2026-04-09T18:30:31Z
dc.date.available2026-04-09T18:30:31Z
dc.date.issued2026-04-01
dc.identifier.citationDiabetes Care Vol.49 No.4 (2026) , 75-76
dc.identifier.doi10.2337/dci26-0008
dc.identifier.eissn19355548
dc.identifier.issn01495992
dc.identifier.pmid41861128
dc.identifier.scopus2-s2.0-105034097011
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/123456789/116013
dc.rights.holderSCOPUS
dc.subjectNursing
dc.subjectMedicine
dc.titleSodium–Glucose Cotransporter 2 Inhibitors, Glucagon-Like Peptide 1 Receptor Agonists, and Frailty Progression in Older Adults With Type 2 Diabetes. Diabetes Care 2026;49:147–151
dc.typeNote
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=105034097011&origin=inward
oaire.citation.endPage76
oaire.citation.issue4
oaire.citation.startPage75
oaire.citation.titleDiabetes Care
oaire.citation.volume49
oairecerif.author.affiliationHarvard Medical School
oairecerif.author.affiliationBeth Israel Deaconess Medical Center
oairecerif.author.affiliationRamathibodi Hospital
oairecerif.author.affiliationHinda and Arthur Marcus Institute for Aging Research

Files

Collections

Scopus 2026